Yoon Loke
Overview
Explore the profile of Yoon Loke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu C, Fan S, Furuya-Kanamori L, Li S, Lin L, Chu H, et al.
BMC Med
. 2024 Oct;
22(1):450.
PMID: 39394146
Background: Trial registration aims to address potential bias from selective or non-reporting of findings, and therefore has a vital role in promoting transparency and accountability of clinical research. In this...
2.
Tay J, Robinson C, Blazeby J, Loke Y, Lowery A, Alkhaffaf B, et al.
J Clin Epidemiol
. 2024 Jul;
174:111474.
PMID: 39038744
Objectives: The objective of this study was to determine the proportion of all published core outcome set (COS) studies that include an adverse event or harm outcome, to determine the...
3.
Hilton A, Megson M, Aryankhesal A, Blake J, Rook G, Irvine A, et al.
Health Expect
. 2024 Mar;
27(2):e14012.
PMID: 38488441
Patient and public involvement and engagement (PPIE) is critically important in healthcare research. A useful starting point for researchers to understand the scope of PPIE is to review the definition...
4.
Xu C, Zhang F, Doi S, Furuya-Kanamori L, Lin L, Chu H, et al.
BMC Med
. 2024 Mar;
22(1):83.
PMID: 38448992
Background: Empirical evidence suggests that lack of blinding may be associated with biased estimates of treatment benefit in randomized controlled trials, but the influence on medication-related harms is not well-recognized....
5.
Alharthi M, Scott S, Hughes C, Bond C, Hatah E, Bryant L, et al.
Int J Pharm Pract
. 2024 Feb;
32(2):180-185.
PMID: 38387608
Background: Medication review (MR) is the systematic assessment of a patient's medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped...
6.
Harris J, Pouwels K, Johnson T, Sterne J, Pithara C, Mahadevan K, et al.
Health Technol Assess
. 2023 Jul;
27(8):1-257.
PMID: 37435838
Background: Bleeding among populations undergoing percutaneous coronary intervention or coronary artery bypass grafting and among conservatively managed patients with acute coronary syndrome exposed to different dual antiplatelet therapy and triple...
7.
Junqueira D, Zorzela L, Golder S, Loke Y, Gagnier J, Julious S, et al.
J Clin Epidemiol
. 2023 Apr;
158:149-165.
PMID: 37100738
Randomized controlled trials remain the reference standard for healthcare research on effects of interventions, and the need to report both benefits and harms is essential. The Consolidated Standards of Reporting...
8.
Junqueira D, Zorzela L, Golder S, Loke Y, Gagnier J, Julious S, et al.
BMJ
. 2023 Apr;
381:e073725.
PMID: 37094878
No abstract available.
9.
Marquette M, Tailor B, Calder P, Curtis P, Loke Y, Wilson A
Curr Allergy Asthma Rep
. 2022 Nov;
22(12):209-229.
PMID: 36374376
Purpose Of Review: Non-steroidal exacerbated respiratory disease (N-ERD) currently requires aspirin challenge testing for diagnosis. Urinary leukotriene E4 (uLTE) has been extensively investigated as potential biomarker in N-ERD. We aimed...
10.
Parretti H, Belderson P, Eborall H, Naughton F, Loke Y, Steel N, et al.
Br J Health Psychol
. 2022 Jul;
28(1):116-135.
PMID: 35880686
Objectives: During COVID-19 the UK general population has been given strong messages to stay at home. Concurrently unprecedented changes occurred in healthcare access with moves to remote/triage systems. Data have...